IntelliCell Biosciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC); ("IntelliCell") or the ("Company"), Dr. Steven Victor, Chairman of IntelliCell Biosciences will be presenting at the BioTech Showcase Conference on January 9, 2012 at 11:30 a.m. (PT). Parc 55 Wyndham San Francisco -Union 55 Cyril Magnin Street San Francisco, CA 94102 Admission Room #2.

IntelliCell Biosciences will webcast their corporate presentation at the Biotech Showcase at 11:30 AM PT on Monday, January 9, 2012 in San Francisco. http://www.media-server.com/m/p/h45jkt45 The webcast may be accessed under "Webcasts" in the Investor Relations section of the Company's website, www.intellicellbiosciences.com. The webcast can be accessed live and will be available for replay after the presentation on the Company's website.

About IntelliCell Biosciences, Inc.

IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using stromal vascular fraction derived from adult adipose tissue. IntelliCell intends to initially focus on setting up tissue processing centers throughout the United States with managing partners. The centers will receive and employ the IntelliCell? process to the adipose stromal vascular fraction harvested by physicians in their own offices, and then return the IntelliCells? to the physicians the same day labeled "autologous homologous." IntelliCell has already established processing centers in New York City, Philadelphia, Dallas/Ft. Worth, and New Orleans, and has entered into a licensing agreement for a center in Palm Beach. In the future, IntelliCell intends to pursue expansion to secondary markets and beyond the U.S. through a combination of company-owned and licensed clinical facilities. For additional information, visit http://www.intellicellbiosciences.com or call 212-249-3050.

For IntelliCell Biosciences, Inc.
Laurel Moody, 646-810-0608